Navigation Links
ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
Date:1/8/2009

LEUVEN, Belgium, January 9 /PRNewswire-FirstCall/ --

- ThromboGenics' Lead Product to be Studied in the Treatment of Vitreomacular Adhesion in the US and Europe

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, announces today that it has started the Phase III clinical program of microplasmin for the non-surgical treatment of back of the eye disease, the final step in the clinical development of this potential new therapy. This program involves two clinical trials, taking place in the United States (TG MV-006 trial) and Europe and North America (TG-MV-007 trial). The start of these pivotal clinical trials represents an important step in potentially improving the treatment of back of the eye disease, and is a major milestone in ThromboGenics' corporate development.

Microplasmin's pivotal Phase III program is referred to as the MIVI-TRUST (Microplasmin for IntraVitreous Injection-Traction Release without Surgical Treatment) program.

The initial indication for both of the Phase III microplasmin trials is the non-surgical treatment of focal vitreomacular adhesion. Focal vitreomacular adhesion is a condition in which the vitreous gel, in the center of the eye, has an abnormally strong adhesion to the retina at the back of the eye. These adhesions can cause vessel and retinal distortion which results in deterioration in the patient's vision. Moreover, vitreomacular adhesion is thought to play a key role in numerous back of the eye conditions such as macular hole formation, and some forms of macular edema. Vitreomacular adhesion is also potentially associated with a much poorer prognosis in certain major eye indications, including diabetic retinopathy and Age-related Macular Degeneration (AMD).

Dr. Steve Pakola, Chief Medical Officer of ThromboGenics, commenting on the announc
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
2. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
3. AFFiRiS Begins Development of a Parkinsons Vaccine
4. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
5. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
6. Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
7. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
8. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
9. Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
10. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
11. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today ... voluntary recall to address a potential issue with ... used for the Axilla application of the SAM ...
(Date:8/29/2014)... PLEASANTON, Calif. , Aug. 29, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... be participating in the 2014 Morgan Stanley Global Healthcare ... F. Burbach , President and Chief Executive Officer, will ... p.m., Eastern Daylight Time (9:55 a.m., Pacific Daylight Time). ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... The two most,prevalent forms of genetic mental retardation, ... cause, according to researchers at,Stanford University School of ... brain, may also be associated with,autism., Although the ... result for the brain seems to be the ...
... YORK--(BUSINESS WIRE)--Apr 12, 2007 - INNOVIVE Pharmaceuticals,Inc. ... of INNO-406, a potent oral dual Bcr-Abl ... leukemia, will be presented at the American ... takes place April,14-18, 2007 at the Los ...
Cached Medicine Technology:Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 2Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 3Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 4Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2
(Date:8/30/2014)... A new batteryless cardiac pacemaker based on an ... presented at ESC Congress 2014 today by Adrian ... require battery replacement. , Mr Zurbuchen, a PhD ... University of Bern, Switzerland, said: "Batteries are a ... reach a critically low energy level, physicians see ...
(Date:8/30/2014)... Malden, MA (PRWEB) August 31, 2014 In ... ‘dog eat dog’ approach, Karma Web Group, LLC launches a ... iOS and Android the newly launched Ultimate Karma app is ... rewarded with new levels of play, the game pulls double-duty ... at the same time. , Designed to reward gamers for ...
(Date:8/30/2014)... Atlanta, GA (PRWEB) August 31, 2014 ... across their dealerships to help raise money and awareness ... Bucket Challenge. , General Managers, staff, and even Vice ... was captured on film and can be viewed on ... to participating in the challenge, general managers and staff ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Truth about ... body that will reveal to users some shocking foods that ... great results in modeling looks, as well as some motivation ... method says that there is one unique trick that can ... indicates that despite what many people might think, cardio exercise ...
(Date:8/30/2014)... 2014 Ticket Down reports that ticket ... match next Saturday at Levi's Stadium. The summer months ... in the United States due to the fact that so many ... major city. Many of these games were practice games in ... summer. , Levi’s Stadium is a brand new facility that will ...
Breaking Medicine News(10 mins):Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2
... Survey Reveals Favorite and Least Favorite Body Parts: ... Jan. 21 Faces and abs top the list ... both men and women, according to a new survey ... non-invasive aesthetic services in the U.S.Nearly a quarter of ...
... for 2009 , ... (Vocus) January 21, 2009 -- ... 2009 according to recent predictions made by the leadership of the ... prediction: a continued growth in consumers who elect to enhance ...
... Jan. 21 Senator Sam Brownback and Rep. ... Council,s Blogs for Life, on ... also feature several prominent conservative voices including Amanda ... Ph.D., Michael Illions, Peter Shinn, Chris Gacek, J.D., ...
... Health Plan Outperforms National Medicaid Plans on Key ... Health Plan (SFHP), the City,s community health plan, ... U.S. leader in childhood immunizations for Medicaid health ... are fully immunized, besting second-ranked Kaiser Permanente of ...
... have different reproductive plans, lifestyles, religious prohibitions, and ... contraceptive choices available, can make selecting the right ... of appropriate and acceptable contraceptive methods can improve ... pregnancy. To address this issue, OBG Management ...
... BALTIMORE, Jan. 21 Physicians Practice and Tucson Medical ... and their staff more time to devote to patient ... to help doctors in the southern Arizona area better ... busy practice. Through this new alliance, Tucson Medical Center ...
Cached Medicine News:Health News:How Does Our Vanity Fare? 2Health News:Cosmetic Injections A Worthwhile Investment 2Health News:Cosmetic Injections A Worthwhile Investment 3Health News:Cosmetic Injections A Worthwhile Investment 4Health News:Senator Sam Brownback and Rep. Cathy McMorris Rodgers to Speak at Blogs for Life 2009 2Health News:San Francisco Health Plan is U.S. Leader in Childhood Immunizations 2Health News:San Francisco Health Plan is U.S. Leader in Childhood Immunizations 3Health News:Physicians Practice and Tucson Medical Center Partner to Improve Patient Care in Southern Arizona 2Health News:Physicians Practice and Tucson Medical Center Partner to Improve Patient Care in Southern Arizona 3
... single-use products to promote safety for your ... catheter reduces cross-contamination and helps protect your ... because cleaning is eliminated, you have more ... water perfused manometric catheters for esophageal, anorectal ...
Esophageal Stylet for LATITUDE® Air-Charged Catheter...
Replacement Stopper for LATITUDE® Air-Charged Catheter...
Manometric Calibration System for LATITUDE® Air-Charged Catheter...
Medicine Products: